Completed
Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein
NCT00529698
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- San Raffaele Hospital Milan, Italy
- Hospital Spallanzani Rome, Italy
- San Gallicano Hospital Rome, Italy
- University of Rome "La Sapienza" Rome, Italy